Tenet Healthcare Corp: Form 10-Q for the period ended Jun 30, 2014
Filed with the SEC on Aug 4, 2014 and accepted by EDGAR at Aug 4, 2014, 16:21 ET.
Sections
The sections of this filing are being extracted from EDGAR and appear here in about a minute. Meanwhile, read the original on sec.gov. The main document on sec.gov.
Figures reported in this filing
Standardized line items from the XBRL in this filing, for the period ended 2014-06-30. Comparative periods it repeats are left out.
| Line item | Period | Value | XBRL concept |
|---|---|---|---|
| Operating income | 3 months2014-04-01 to 2014-06-30 | $207.0m | us-gaap:OperatingIncomeLoss |
| Operating income | 6 months2014-01-01 to 2014-06-30 | $377.0m | us-gaap:OperatingIncomeLoss |
| Interest expense | 3 months2014-04-01 to 2014-06-30 | $190.0m | us-gaap:InterestExpense |
| Interest expense | 6 months2014-01-01 to 2014-06-30 | $372.0m | us-gaap:InterestExpense |
| Income tax | 3 months2014-04-01 to 2014-06-30 | $8.0m | us-gaap:IncomeTaxExpenseBenefit |
| Income tax | 6 months2014-01-01 to 2014-06-30 | $7.0m | us-gaap:IncomeTaxExpenseBenefit |
| Net income | 3 months2014-04-01 to 2014-06-30 | −$7.0m | us-gaap:ProfitLoss |
| Net income | 6 months2014-01-01 to 2014-06-30 | −$23.0m | us-gaap:ProfitLoss |
| Diluted EPS | 3 months2014-04-01 to 2014-06-30 | −$0.27 | us-gaap:EarningsPerShareDiluted |
| Diluted EPS | 6 months2014-01-01 to 2014-06-30 | −$0.60 | us-gaap:EarningsPerShareDiluted |
| Basic EPS | 3 months2014-04-01 to 2014-06-30 | −$0.27 | us-gaap:EarningsPerShareBasic |
| Basic EPS | 6 months2014-01-01 to 2014-06-30 | −$0.60 | us-gaap:EarningsPerShareBasic |
| Diluted shares (weighted) | 3 months2014-04-01 to 2014-06-30 | 97,677,000 shares | us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding |
| Diluted shares (weighted) | 6 months2014-01-01 to 2014-06-30 | 97,419,000 shares | us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding |
| Operating cash flow | 6 months2014-01-01 to 2014-06-30 | $247.0m | us-gaap:NetCashProvidedByUsedInOperatingActivities |
| Capital expenditure | 6 months2014-01-01 to 2014-06-30 | $523.0m | us-gaap:PaymentsToAcquirePropertyPlantAndEquipment |
| Share repurchases | 6 months2014-01-01 to 2014-06-30 | $0 | us-gaap:PaymentsForRepurchaseOfCommonStock |
| Cash and equivalents | At period end2014-06-30 | $406.0m | us-gaap:CashAndCashEquivalentsAtCarryingValue |
| Current assets | At period end2014-06-30 | $4.21bn | us-gaap:AssetsCurrent |
| Total assets | At period end2014-06-30 | $16.91bn | us-gaap:Assets |
| Current liabilities | At period end2014-06-30 | $3.38bn | us-gaap:LiabilitiesCurrent |
| Total liabilities | At period end2014-06-30 | $15.76bn | us-gaap:Liabilities |
| Shareholders' equity | At period end2014-06-30 | $723.0m | us-gaap:StockholdersEquity |
Source: SEC EDGAR, the filing index for accession 0001104659-14-056402. Last ingested by Listed: Nov 15, 2026, 02:42 ET. Listed shows no prices and gives no investment advice.